Objectives: The aim of the study was to evaluate self-reported MADE during the COVID-19 pandemic in dental healthcare practitioners and identify their possible risk factors. Material and Methods: An anonymous questionnaire was sent to doctors of dental medicine in the time period from February 2022 to August 2022. The online questionnaire included demographic characteristics and clinical characteristics: presence and deterioration of DED symptoms while wearing the face mask, person-al protective face equipment, use of contact lenses, history of eye surgery, current use of medica-tions, number of hours wearing face mask, and evaluation of subjective DED symptoms using mod-ified Ocular Surface Disease Index (OSDI). Results: A total of 405 participants were included in the study and an overall prevalence of MADE was 29.1% (95% CI: 24.7 -33.6). The participants who used masks more than 6 hours per day during the whole day reported a higher OSDI score (12.5 (IQR = 2.6 - 29.2)) compared to the participants who used masks less than 6 hours/day (6.25 (IQR = 0 - 22.92); Mann-Whitney U Test p = 0.066). Multivariable logistic regression revealed the following possible risk factors for self-reported MADE: age (older than 61 years) OR: 3.522 (95% CI 1.448 -8.563); p=0.05, and wearing the face mask more than 6 h at work OR: 1.779 (95% CI 1.017 - 3.113); p=0.044. Conclusion: The prevalence of self-reported MADE among dental healthcare practitioners appears to be significant. The use of a face mask for a prolonged duration increases OSDI scores. MeSH Terms: face masks, dry eye, MADE, ocular discomfort, COVID-19, protective face equipment
The aim of this study was to analyse the postoperative corneal cross-linking results of corneal parameters and the ABCD grading system, depending on the cone location. Thirty eyes of 25 patients with keratoconus (KC), who received the corneal cross-linking (CXL) treatment, were included in this study. The exclusion criteria were: patients under 18 years of age, corneal pachymetry less than 400 μm, corneal scarring, history of ocular trauma, history of ocular surgery, and corneal pathology other than KC. Patients were examined at the baseline visit, and followed-up at three, six, and twelve months after the CXL. All patients underwent visual acuity and Scheimpflug tomography at all visits. Progression parameters, keratometries, and ABCD grading were compared between the visits. Patients were classified into two groups: central and paracentral cones group (within the central 5 mm corneal zone) and peripheral cones group (outside the central 5 mm corneal zone), based on X-Y coordinates of maximal keratometry (Kmax). Parameter A remained relatively stable throughout the follow-up period in both groups. Parameter B and parameter C showed a significant increase in both groups postoperatively. Parameter D showed stability at the 6-month post-CXL visit in the peripheral KC group, while the central and paracentral KC group showed improvement at the 12-month post-CXL visit. There was no significant difference in the postoperative response between different cone locations in the ABCD grading system, when classifying according to the Kmax, except an earlier recovery of the parameter D in peripherally located cones.
Purpose: To assess the efficacy of topical insulin for the treatment of various ocular surface diseases. Methods: A retrospective, multicenter cohort study was conducted at the university hospitals of Brussels and Ghent and included 57 eyes (45 patients) treated with topical insulin (1 IU/mL 4 times daily) for neurotrophic keratopathy (NK) (n = 31), dry eye disease (DED) (n = 9), graft-versus-host disease (GVHD) (n = 7), and various other ocular surface diseases (n = 10) between October 2023 and March 2025. Data from medical records and anterior segment photographs were analyzed. Primary outcome was treatment success; secondary outcomes included clinical evolution, symptoms, data on persistent epithelial defects (PED), vision, and adverse events. Results: Treatment success was highest in NK eyes (83.9%) as compared to DED and GVHD eyes (44.4% and 14.3%, respectively), with a statistically significant difference between NK and GVHD ( P = 0.028). Treatment success did not differ significantly between eyes with NK grade 1, 2, and 3 (83.3%, 72.7%, and 92.9%, respectively) (all P > 0.05). Twenty out of 28 (71.4%) PED eyes of various etiologies achieved complete closure after 5.2 weeks, whereas 6 eyes (21.4%) showed partial closure, and 2 eyes (7.1%) showed no improvement. One eye showed a significant transient IOP increase; no other adverse events were noted. Conclusions: These results suggest that topical insulin drops are a safe and affordable treatment option for ocular surface diseases, particularly for NK eyes with and without PED. Further prospective clinical trials, however, are needed to confirm the efficacy and define the place of topical insulin in standardized treatment protocols.
Background and Objectives: To assess refractive and visual outcomes following phacoemulsification using a novel algorithm for toric intraocular lens (IOL) surgery. Setting: Private practice, Spain. Design: Prospective observational study. Materials and Methods: The algorithm was designed to control the topographic position of the principal meridians (flat and steep) after cataract surgery in eyes without associated corneal pathology or previous corneal surgery. It is well known that a toric IOL must be positioned along the steep meridian. Therefore, it is crucial to predict both the postoperative position of the steep meridian and its magnitude. Data from patients who were planned for refractive lens exchange or cataract surgery using the Pešić-Barraquer algorithm and implantation of a toric IOL in eyes with different degrees of astigmatism were used to assess the effect of residual astigmatism on 6-month postoperative monocular uncorrected and corrected distance logMAR visual acuity values (UDVA and CDVA). Vector analysis was performed with J0 and J45 evaluations, and centroid errors in postoperative refractive astigmatism prediction error were calculated in the spectacle plane using the “Astigmatism Double-Angle Plot Tool”. Results: Three hundred and six eyes of 250 patients with a mean age of 69.0 years ± 8.6 were enrolled in the study. The mean preoperative corneal astigmatism measured with Pentacam was 1.43 D ± 0.83 (SD). One hundred and eighty-four eyes (60.13%) had “against-the-rule” (ATR) astigmatism, 67 (21.90%) had “with-the-rule” (WTR) astigmatism, and 55 (17.97%) eyes had “oblique” corneal (OBL) astigmatism preoperatively. The mean absolute astigmatic prediction error in residual astigmatism was 0.31 D ± 0.28. Eyes with preoperative ATR corneal astigmatism had lower mean absolute errors compared to the eyes with WTR astigmatism (0.29 D ± 0.26 and 0.34 D ± 0.31, respectively). Centroid error in predicted residual astigmatism was 0.08 D ± 0.41 @4°. All eyes achieved residual refractive astigmatism within the 1.00 D range, and 55.23% had no residual astigmatism in the spectacle plane. Mean postoperative refractive astigmatism at the spectacle plane was 0.24 D ± 0.29. There were no postoperative complications. Additional statistical analysis of 310 eyes confirmed that when the main incision is not placed on one of the three meridians (flat, steep, or 45-degree bisector), the axis of astigmatism induced by the incision is significantly altered. Exploratory subgroup analyses demonstrated comparable prediction accuracy across incision positions, preoperative astigmatism types, and surgeons, further supporting the robustness of the proposed algorithm. Conclusions: In addition to enabling more accurate prediction of postoperative refractive residual astigmatism in patients undergoing toric IOL implantation, our newly proposed algorithm provides surgical pearls to facilitate preoperative and intraoperative management of corneal astigmatism, highlighting the importance of precise incision placement for optimal refractive outcomes.